Live Breaking News & Updates on National guidelines for stem cell research

Stay informed with the latest breaking news from National guidelines for stem cell research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in National guidelines for stem cell research and stay connected to the pulse of your community

How subpar treatment options allow sickle cell disease to persist | Explained

How subpar treatment options allow sickle cell disease to persist | Explained
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

India , Odisha , Orissa , Georgia , United-states , Democratic-republic-of-the-congo , Sambalpur , Burla , India-general- , Nigeria , Janice-haney-carr , National-guidelines-for-gene-therapy-product-development

CRISPR Technology Global Market Report 2023: Usage in Diagnostics Set to Catalyse Growth

/PRNewswire/ -- The "CRISPR Technology Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global crispr technology...

United-states , India , Dublin , Ireland , Russia , Ukraine , America , Transposagenbio-biophramaceuticals-hera-biolabs , Laura-wood , Lonza-group-ltd , Origene-technologies-inc , Intellia-therapeutics-inc

CRISPR Technology Global Market Report 2022: Use of CRISPR in Diagnostics to Bolster 23.7% Annual Growth

/PRNewswire/ -- The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to...

Australia , India , Dublin , Ireland , Australian , Transposagenbio-biophramaceuticals-hera-biolabs , Laura-wood , Origene-technologies-inc , Intellia-therapeutics-inc , Technology-market-characteristics , Sherlock-biosciences-inc-crispr-sars-co , Merck-kga

CRISPR Technology Global Market Report 2022: Use of CRISPR in Diagnostics to Bolster 23.7% Annual Growth

/PRNewswire/ -- The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to...

Australia , India , Dublin , Ireland , Australian , Transposagenbio-biophramaceuticals-hera-biolabs , Laura-wood , Origene-technologies-inc , Intellia-therapeutics-inc , Technology-market-characteristics , Sherlock-biosciences-inc-crispr-sars-co , Merck-kga

CRISPR Technology Global Market Report 2022

Major players in the market are Thermo Fisher Scientific, GenScript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Horizon Discovery Plc. ,...

Germany , New-york , United-states , Australia , Japan , India , United-kingdom , Brazil , China , Indonesia , South-korea , Russia

Global CRISPR Technology Market Report 2020: COVID-19 Growth and Change - Market is Expected to Recover to Reach $1.55 Billion in 2023

Share this article
Share this article
ResearchAndMarkets.com's offering.
CRISPR Technology Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global crispr technology market.
Major players in the CRISPR technology market are Thermo Fisher Scientific, GenScript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Horizon Discovery Plc., Integrated DNA Technologies, Inc. (Danaher), Origene Technologies, Inc., Transposagenbio Biopharmaceuticals (Hera Biolabs), Intellia Therapeutics Inc., and GeneCopoeia, Inc.
The global CRISPR technology market is expected to increase from $0.76 billion in 2019 to $0.92 billion in 2020 at a compound annual growth rate (CAGR) of 20.91%. The exponential growth is mainly due to the COVID-19 outbreak that has led to the research for drugs for COVID-19 with gene-editing using CRISPR technology. The market is expected to reach $1.55 billion in 2023 at a CAGR of 19.13%.

Australia , United-states , India , Dublin , Ireland , America , Australian , Biophramaceuticals-hera-biolabs , Hera-biolabs , Cardea-bio , Laura-wood , Origene-technologies-inc